Trifarotene, minocycline, and clascoterone are new effective drugs for the topical treatment of acne in children and adults.
FDA
Posted inNew Drugs, Rare/Orphan Diseases, Regulatory
Trikafta/Kaftrio: World’s First Triple Therapy for Cystic Fibrosis
The combination drug will help almost all cystic fibrosis patients.
Posted inNew Drugs, Rare/Orphan Diseases, Regulatory
Voxzogo: First Drug to Treat Dwarfism
Vosoritide by BioMarin Pharmaceutical may cure achondroplasia.
Posted inInfections, New Drugs, Regulatory
Livtencity: New Drug Against Post-Transplant Cytomegalovirus Infection
Maribavir will suppress cytomegalovirus when ganciclovir, valganciclovir, cidofovir, or foscarnet do not work.
Posted inNew Drugs, Oncology, Rare/Orphan Diseases, Regulatory
Fyarro: First Drug to Treat Perivascular Epithelioid Cell Tumor
PEComa is a very rare and aggressive subtype of soft tissue sarcoma.
Posted inNew Drugs, Regulatory
StrataGraft: Artificial Skin for Treatment of Severe Thermal Burns
Mallinckrodt has offered an effective alternative to autograft procedures.
Posted inCOVID-19, Infections, Regulatory
Molnupiravir: What U.S. Experts Said
FDA scientists took a detailed look at molnupiravir for treating COVID-19.